Back to Search
NISHA HARIHARAN, MD
MD
Hematology & Oncology Physician
NPI: 1679004543IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
A157468(CA)
Education
PENNSYLVANIA STATE UNIVERSITY COLLEGE OF MEDICINE
Class of 2023
Research & Publications (16)
Novel methods for measuring cardiac autophagy in vivo.
PMID 19216914·Methods Enzymol·2009
7-preclinical
Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes.
PMID 19661458·Circ Res·2009
7-preclinical
Design, synthesis and structure-activity relationships of azole acids as novel, potent dual PPAR alpha/gamma agonists.
PMID 19201606·Bioorg Med Chem Lett·2009
4-observational
Genetic and gene expression studies implicate renin and endothelin-1 in edema caused by peroxisome proliferator-activated receptor gamma agonists.
PMID 18794727·Pharmacogenet Genomics·2008
2-rct
Design, synthesis, and structure-activity relationships of piperidine and dehydropiperidine carboxylic acids as novel, potent dual PPARalpha/gamma agonists.
PMID 18511276·Bioorg Med Chem Lett·2008
8-other
Discovery of azetidinone acids as conformationally-constrained dual PPARalpha/gamma agonists.
PMID 18291645·Bioorg Med Chem Lett·2008
7-preclinical
Molecular mechanisms and physiological significance of autophagy during myocardial ischemia and reperfusion.
PMID 18227645·Autophagy·2008
6-review
Discovery of tertiary aminoacids as dual PPARalpha/gamma agonists-I.
PMID 17292606·Bioorg Med Chem Lett·2007
7-preclinical
A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARalpha/gamma activator.
PMID 17335769·Anal Biochem·2007
8-other
The dual peroxisome proliferator-activated receptor alpha/gamma activator muraglitazar prevents the natural progression of diabetes in db/db mice.
PMID 17259449·J Pharmacol Exp Ther·2007
7-preclinical
Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
PMID 17062777·Drug Metab Dispos·2007
3-trial
Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.
PMID 16380499·Diabetes·2006
7-preclinical
Pharmacokinetics of muraglitazar (BMS-298585), a dual peroxisome proliferator-activated receptors (PPAR) alpha and gamma activator, in mice, rats, dogs, and monkeys.
PMID 17162469·Xenobiotica·2006
7-preclinical
Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist with efficacious glucose and lipid-lowering activities.
PMID 15771468·J Med Chem·2005
7-preclinical
Folic acid supplementation enhances repair of the adult central nervous system.
PMID 15293274·Ann Neurol·2004
4-observational
Spinal cord regeneration induced by a voltage-gated calcium channel agonist.
PMID 12392197·Neurol Res·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3100 SAN PABLO AVE STE 280
BERKELEY, CA 94702 - Phone
- (510) 420-8000
Quick Facts
- NPI
- 1679004543
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 3
- Publications
- 16
Are you this provider?
Claim Your Profile